R01 CA101840-05/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.

Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Leeman-Neill RJ, et al. Clin Cancer Res. 2010 May 1;16(9):2571-9. doi: 10.1158/1078-0432.CCR-10-0333. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388852 Free PMC article.

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR. Wheeler SE, et al. Oncogene. 2010 Sep 16;29(37):5135-45. doi: 10.1038/onc.2009.279. Epub 2010 Jul 12. Oncogene. 2010. PMID: 20622897 Free PMC article.

Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer.

Yang W, Cai Q, Lui VW, Everley PA, Kim J, Bhola N, Quesnelle KM, Zetter BR, Steen H, Freeman MR, Grandis JR. Yang W, et al. J Proteome Res. 2010 Jun 4;9(6):3073-82. doi: 10.1021/pr901211j. J Proteome Res. 2010. PMID: 20426488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters